| Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial E Basch, AM Deal, MG Kris, HI Scher, CA Hudis, P Sabbatini, L Rogak, ... Journal of Clinical Oncology 34 (6), 557, 2016 | 2165 | 2016 |
| Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) E Basch, BB Reeve, SA Mitchell, SB Clauser, LM Minasian, AC Dueck, ... Journal of the National Cancer Institute 106 (9), dju244, 2014 | 862 | 2014 |
| Validity and reliability of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) AC Dueck, TR Mendoza, SA Mitchell, BB Reeve, KM Castro, LJ Rogak, ... JAMA oncology 1 (8), 1051-1059, 2015 | 698 | 2015 |
| Electronic patient‐reported outcome systems in oncology clinical practice AV Bennett, RE Jensen, E Basch CA: a cancer journal for clinicians 62 (5), 336-347, 2012 | 367 | 2012 |
| The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review TM Atkinson, SJ Ryan, AV Bennett, AM Stover, RM Saracino, LJ Rogak, ... Supportive Care in Cancer 24, 3669-3676, 2016 | 329 | 2016 |
| Reliability of adverse symptom event reporting by clinicians TM Atkinson, Y Li, CW Coffey, L Sit, M Shaw, D Lavene, AV Bennett, ... Quality of life research 21, 1159-1164, 2012 | 229 | 2012 |
| The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) ES Hwang, T Hyslop, T Lynch, E Frank, D Pinto, D Basila, D Collyar, ... BMJ open 9 (3), e026797, 2019 | 222 | 2019 |
| Cognitive interviewing of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) JL Hay, TM Atkinson, BB Reeve, SA Mitchell, TR Mendoza, G Willis, ... Quality of Life Research 23, 257-269, 2014 | 155 | 2014 |
| Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy TJ Judson, AV Bennett, LJ Rogak, L Sit, A Barz, MG Kris, CA Hudis, ... Journal of clinical oncology 31 (20), 2580, 2013 | 151 | 2013 |
| Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial E Basch, D Schrag, S Henson, J Jansen, B Ginos, AM Stover, P Carr, ... Jama 327 (24), 2413-2422, 2022 | 125 | 2022 |
| Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events E Basch, A Bennett, MC Pietanza Journal of the National Cancer Institute 103 (24), 1808-1810, 2011 | 123 | 2011 |
| Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial E Basch, AM Stover, D Schrag, A Chung, J Jansen, S Henson, P Carr, ... JCO clinical cancer informatics 4, 947-957, 2020 | 110 | 2020 |
| The project data sphere initiative: accelerating cancer research by sharing data AK Green, KE Reeder-Hayes, RW Corty, E Basch, MI Milowsky, ... The oncologist 20 (5), 464-e20, 2015 | 106 | 2015 |
| Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the US National Cancer Institute’s Patient … AV Bennett, AC Dueck, SA Mitchell, TR Mendoza, BB Reeve, TM Atkinson, ... Health and quality of life outcomes 14, 1-12, 2016 | 102 | 2016 |
| Emerging uses of patient generated health data in clinical research WA Wood, AV Bennett, E Basch Molecular oncology 9 (5), 1018-1024, 2015 | 97 | 2015 |
| Composite grading algorithm for the National cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) E Basch, C Becker, LJ Rogak, D Schrag, BB Reeve, P Spears, ML Smith, ... Clinical Trials 18 (1), 104-114, 2021 | 92 | 2021 |
| SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials M Calvert, M King, R Mercieca-Bebber, O Aiyegbusi, D Kyte, A Slade, ... BMJ open 11 (6), e045105, 2021 | 90 | 2021 |
| Feasibility of patient reporting of symptomatic adverse events via the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a … E Basch, SL Pugh, AC Dueck, SA Mitchell, L Berk, S Fogh, LJ Rogak, ... International Journal of Radiation Oncology* Biology* Physics 98 (2), 409-418, 2017 | 90 | 2017 |
| Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review SR Gandra, FO Finkelstein, AV Bennett, EF Lewis, T Brazg, ML Martin American journal of kidney diseases 55 (3), 519-534, 2010 | 85 | 2010 |
| PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force S Eremenco, SJ Coons, J Paty, K Coyne, AV Bennett, D McEntegart Value in Health 17 (5), 501-516, 2014 | 76 | 2014 |
